173 related articles for article (PubMed ID: 11755153)
1. Tachykinin NK(3) receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways.
Daoui S; Ahnaou A; Naline E; Emonds-Alt X; Lagente V; Advenier C
Eur J Pharmacol; 2001 Dec; 433(2-3):199-207. PubMed ID: 11755153
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin B- and specific tachykinin NK(3) receptor agonists-induced airway hyperresponsiveness in the guinea-pig.
Daoui S; Naline E; Lagente V; Emonds-Alt X; Advenier C
Br J Pharmacol; 2000 May; 130(1):49-56. PubMed ID: 10780997
[TBL] [Abstract][Full Text] [Related]
3. Involvement of tachykinin NK1 and NK2 receptors in substance P-induced microvascular leakage hypersensitivity and airway hyperresponsiveness in guinea-pigs.
Boichot E; Biyah K; Germain N; Emonds-Alt X; Lagente V; Advenier C
Eur Respir J; 1996 Jul; 9(7):1445-50. PubMed ID: 8836657
[TBL] [Abstract][Full Text] [Related]
4. SR 140333 prevents potentiation by citric acid of plasma exudation induced by histamine in airways.
Biyah K; Molimard M; Emonds-Alt X; Advenier C
Eur J Pharmacol; 1996 Jul; 308(3):325-8. PubMed ID: 8858307
[TBL] [Abstract][Full Text] [Related]
5. A tachykinin NK3 receptor antagonist, SR 142801 (osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs.
Daoui S; Cui YY; Lagente V; Emonds-Alt X; Advenier C
Pulm Pharmacol Ther; 1997; 10(5-6):261-70. PubMed ID: 9778489
[TBL] [Abstract][Full Text] [Related]
6. Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs.
Daoui S; Cognon C; Naline E; Emonds-Alt X; Advenier C
Am J Respir Crit Care Med; 1998 Jul; 158(1):42-8. PubMed ID: 9655705
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory and motor responses by tachykinins in the guinea-pig oesophageal sphincter.
Conte B; Parlani M; Lopez G; Cirillo R; Maggi CA; Manzini S
J Auton Pharmacol; 1998 Oct; 18(5):313-7. PubMed ID: 9831232
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.
Kerr KP; Thai B; Coupar IM
Br J Pharmacol; 2000 Dec; 131(7):1461-7. PubMed ID: 11090121
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin NK(3)receptor involvement in anxiety.
Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC
Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
12. SCH 206272: a potent, orally active tachykinin NK(1), NK(2), and NK(3) receptor antagonist.
Anthes JC; Chapman RW; Richard C; Eckel S; Corboz M; Hey JA; Fernandez X; Greenfeder S; McLeod R; Sehring S; Rizzo C; Crawley Y; Shih NY; Piwinski J; Reichard G; Ting P; Carruthers N; Cuss FM; Billah M; Kreutner W; Egan RW
Eur J Pharmacol; 2002 Aug; 450(2):191-202. PubMed ID: 12206858
[TBL] [Abstract][Full Text] [Related]
13. Bronchoconstrictor effect of the tachykinin NK₃-receptor agonists [MePhe⁷]-neurokinin B and senktide in the isolated guinea pig lung.
Corboz MR; Rivelli MA; Eckel SP
Exp Lung Res; 2010 Nov; 36(9):509-21. PubMed ID: 20939761
[TBL] [Abstract][Full Text] [Related]
14. Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands.
Phillips JE; Hey JA; Corboz MR
Br J Pharmacol; 2003 Jan; 138(1):254-60. PubMed ID: 12522097
[TBL] [Abstract][Full Text] [Related]
15. Involvement of NK1 and NK2 receptors in pulmonary responses elicited by non-adrenergic, non-cholinergic vagal stimulation in guinea-pigs.
Savoie C; Tousignant C; Rodger IW; Chan CC
J Pharm Pharmacol; 1995 Nov; 47(11):914-20. PubMed ID: 8708985
[TBL] [Abstract][Full Text] [Related]
16. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.
Advenier C; Qian Y; Koune JD; Molimard M; Candenas ML; Naline E
Br J Pharmacol; 1992 Apr; 105(4):792-8. PubMed ID: 1354535
[TBL] [Abstract][Full Text] [Related]
17. Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function.
Hagan RM; Ireland SJ; Jordan CC; Beresford IJ; Deal MJ; Ward P
Neuropeptides; 1991 Jun; 19(2):127-35. PubMed ID: 1719445
[TBL] [Abstract][Full Text] [Related]
18. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin receptors in the guinea-pig isolated bronchi.
Maggi CA; Patacchini R; Quartara L; Rovero P; Santicioli P
Eur J Pharmacol; 1991 May; 197(2-3):167-74. PubMed ID: 1717290
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
